Next-gen obesity biotech Metsera has filed to debut on the public markets, proposing an IPO nine months after emerging. | ...

Metsera has filed for an initial public offering. The clinical-stage biopharmaceutical company submitted a registration statement to regulators on Friday, saying it intends to list under the ticker ...

The terms of the IPO were not disclosed in the filing. Strong equity markets, falling interest rates and hopes of a ...

The stock's fall snapped a two-day winning streak.

Discover why Arch Capital Group Ltd.'s recent share price weakness presents a buying opportunity with strong fundamentals.

It certainly was a big week — with companies having to raise more than $100 million to make the list. Biotech- and healthcare ...

A new company is making its debut with a series A sum that’s sure to make hearts race. | A new company is making its debut ...

The Overhaul Group Inc. said Jan. 10 that it raised a $55 million growth investment. The new backing was led by New ...

“Jami is an industry-leading intellect and advisor to transformational healthcare companies,” said Mark Van Lith, CEO of Guggenheim Securities. “Jami is an important addition to our premier healthcare ...